Ngā hua rapu - H Dietzfelbinger

  • E whakaatu ana i te 1 - 2 hua o te 2
Whakamahine hua
  1. 1
    Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer

    Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer mā Florian Lordick, Sylvie Lorenzen, J. Stollfuß, Ursula Vehling‐Kaiser, Frank Kullmann, Marcus Hentrich, R. Zumschlinge, H Dietzfelbinger, Jutta Thoedtmann, Michael Hennig, T. Seroneit, Rainer Bredenkamp, Justus Duyster, C. Peschel

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104—A Randomized Trial of the German AIO CRC Study Group

    Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK... mā Nicolas Moosmann, Ludwig Fischer von Weikersthal, Ursula Vehling‐Kaiser, Martina Stauch, Holger G. Hass, H Dietzfelbinger, Daniel Oruzio, Stefan Klein, Klaus Zellmann, Thomas Decker, Mathias Schulze, Wolfgang Abenhardt, Gerhard Puchtler, Herbert Kappauf, J. Mittermüller, C. Haberl, Andreas Schalhorn, Andreas Jung, Sebastian Stintzing, Volker Heinemann

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: